As of close of business last night, Alector Inc’s stock clocked out at $5.82, down -5.52% from its previous closing price of $6.16. In other words, the price has decreased by -$0.34 from its previous closing price. On the day, 513318 shares were traded.
Ratios:
To gain a deeper understanding of ALEC’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.18 and its Current Ratio is at 3.18. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.23.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on December 14, 2023, Upgraded its rating to Buy and sets its target price to $15 from $8 previously.
On December 12, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $12.
On September 25, 2023, Goldman started tracking the stock assigning a Sell rating and target price of $4.Goldman initiated its Sell rating on September 25, 2023, with a $4 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 04 ’24 when Rosenthal Arnon sold 18,837 shares for $6.92 per share. The transaction valued at 130,386 led to the insider holds 2,000,380 shares of the business.
Kenkare-Mitra Sara sold 10,169 shares of ALEC for $70,387 on Mar 04 ’24. The President and Head of R&D now owns 318,847 shares after completing the transaction at $6.92 per share. On Mar 04 ’24, another insider, Romano Gary, who serves as the Chief Medical Officer of the company, sold 6,001 shares for $6.92 each. As a result, the insider received 41,554 and left with 196,313 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALEC now has a Market Capitalization of 556.30M and an Enterprise Value of 46.36M. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.74 while its Price-to-Book (P/B) ratio in mrq is 3.68. Its current Enterprise Value per Revenue stands at 0.48 whereas that against EBITDA is -0.32.
Stock Price History:
Over the past 52 weeks, ALEC has reached a high of $9.06, while it has fallen to a 52-week low of $3.66. The 50-Day Moving Average of the stock is 6.29, while the 200-Day Moving Average is calculated to be 6.33.
Shares Statistics:
It appears that ALEC traded 696.21K shares on average per day over the past three months and 431.51k shares per day over the past ten days. A total of 84.88M shares are outstanding, with a floating share count of 72.80M. Insiders hold about 23.96% of the company’s shares, while institutions hold 65.53% stake in the company. Shares short for ALEC as of Mar 15, 2024 were 5.85M with a Short Ratio of 8.40, compared to 5.23M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 6.11% and a Short% of Float of 7.78%.
Earnings Estimates
As of right now, 10 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.49 for the current quarter, with a high estimate of -$0.34 and a low estimate of -$0.64, while EPS last year was -$0.55. The consensus estimate for the next quarter is -$0.52, with high estimates of -$0.38 and low estimates of -$0.64.
Analysts are recommending an EPS of between -$1.49 and -$2.33 for the fiscal current year, implying an average EPS of -$2.05. EPS for the following year is -$1.77, with 8 analysts recommending between -$0.43 and -$2.56.
Revenue Estimates
In the current quarter, 7 analysts expect revenue to total $15.01M. It ranges from a high estimate of $16.3M to a low estimate of $10M. As of the current estimate, Alector Inc’s year-ago sales were $16.55M, an estimated decrease of -9.30% from the year-ago figure. For the next quarter, 7 analysts are estimating revenue of $15.01M, a decrease of -73.30% less than the figure of -$9.30% in the same quarter last year. There is a high estimate of $16.3M for the next quarter, whereas the lowest estimate is $10M.
A total of 11 analysts have provided revenue estimates for ALEC’s current fiscal year. The highest revenue estimate was $65M, while the lowest revenue estimate was $50M, resulting in an average revenue estimate of $61.89M. In the same quarter a year ago, actual revenue was $97.06M, down -36.20% from the average estimate. Based on 10 analysts’ estimates, the company’s revenue will be $130.62M in the next fiscal year. The high estimate is $260M and the low estimate is $42.84M. The average revenue growth estimate for next year is up 111.10% from the average revenue estimate for this year.
